HEAD OF DEVELOPMENT SCIENCES
Mark Dresser serves as the Head of Development Sciences at Denali. Mark was previously the Director and Head of the Oncology Clinical Pharmacology Department and the Atezolizumab (anti-PDL1) Project Team Leader at Genentech. He started his industry career at ALZA Corporation, a Johnson & Johnson Company, where he was an Associate Director in the Department of Clinical Pharmacology. Mark’s experience spans all phases of drug development and includes over 40 successful IND filings and global regulatory approvals of four novel oncology drugs. Mark earned his Ph.D. in Pharmaceutical Chemistry from UCSF and his B.S. and M.S. degrees in Chemistry from Rensselaer Polytechnic Institute and the Swiss Federal Institute of Technology.